Cancer Explained

Can prostate cancer treatment really be completed in just five sessions?
 
In this episode of Cancer Explained, Dr. Seth Blacksburg speaks with Dr. Jonathan Haas, Chair of Radiation Oncology at NYU Langone Hospital Long Island and a pioneer in prostate stereotactic body radiation therapy (SBRT).
They discuss how advances in radiation technology now allow many prostate cancer patients to complete treatment in five or fewer sessions while achieving excellent outcomes. Dr. Haas explains what SBRT is, who may benefit, how it compares with surgery, potential side effects, and why precision is so important.
Drawing on decades of experience, he offers practical advice and reassurance for patients navigating a prostate cancer diagnosis, highlighting the importance of informed decision-making and expert care.
An accessible and empowering conversation for patients, caregivers, and anyone interested in advances in cancer treatment.
 

What have we learned from treating and following prostate cancer patients for more than two decades? Prof. Sean Collins joins Dr. Seth Blacksburg to discuss modern radiation therapy, long-term outcomes, quality of life, and how evidence from thousands of patients continues to shape prostate cancer care today.
 

Dr. Seth Blacksburg is joined by Professor Giuseppe “Pepe” Sasso for an in-depth conversation about prostate cancer, clinical decision-making, and the evolution of precision radiation therapy.
They discuss how prostate cancer is diagnosed, why many cases can allow time for thoughtful treatment decisions, and how PSA, imaging, and disease characteristics help guide care. The conversation also examines stereotactic radiation, CyberKnife, treatment precision, and the importance of tailoring cancer care to the individual patient while balancing outcomes and quality of life.

What happens after someone hears the words “you have prostate cancer”? Dr. Seth Blacksburg sits down with urologic oncology expert Dr. Lee Richstone to explain the first steps of the prostate cancer journey, from PSA screening and biopsy to Gleason scores, MRI, PSMA PET imaging, and risk classification.
They also explore why prostate cancers can behave so differently, when active surveillance may be appropriate, and how physicians weigh cancer risk alongside age, overall health, urinary and sexual function, quality of life, and patient preferences when discussing treatment. It is a practical, patient-centered conversation about understanding the diagnosis before making decisions.

Dr. Eduardo Lovo joins Dr. Seth Blacksburg to discuss how radiosurgery is changing the treatment of brain tumors and neurological disorders. They explore the science behind focused radiation, how non-invasive treatments compare with traditional surgery, and why precision, patient-centered care, and expanding access to advanced technology are shaping the future of medicine.
This episode offers an accessible, evidence-based look at one of the most exciting advances in modern neuroscience and radiation oncology.

Professor Alexander Muacevic joins Dr. Seth Blacksburg to discuss the evolution of radiosurgery and how advances in precision radiation technology are expanding treatment options for patients with brain, spine, kidney, prostate, and other tumors.
They explore the science behind radiosurgery, why precision matters, how patient trust is built through education and time, and how innovation continues to improve outcomes while minimizing the impact of treatment. This episode offers an accessible, evidence-based look at one of the most significant advances in modern cancer care.